Prof Yorgancioğlu is  a fellow of the European Respiratory Society (ERS) and the American Thoracic Society (ATS), is the current chair of the Global Initiative for Asthma (GINA) Board of Directors, coordinator of the Reference Site of European Innovation Partnership on Active and Healthy Aging (EIP on AHA) in Turkey, and is a member of the UN Environment MCTOC. She is the  past chair of the WHO  GARD (Global Alliance against Respiratory Diseases) and  the  Advocacy Council Chair of the ERS Executive Committee.

Prof van Boven is the head of a multidisciplinary clinical, academic research group focusing on maximizing the clinical and societal benefits of respiratory medicines.

Professor Hurst is an academic pulmonologist with clinical and research interests in chronic obstructive pulmonary disease (COPD).

Prof Trudzinski is a board‑certified pulmonologist with additional qualifications in infectiology and intensive care medicine. Her clinical and scientific focus lies in COPD, alpha‑1 antitrypsin deficiency, and intensive care management.

Dr Kaplan is the Chairperson of the Family Physician Airways Group of Canada and is the medical director of the Pulmonary Rehabilitation program for the local health integration network. He co-chaired the Community Standards of COPD program for Health Quality Ontario.

Tonya Winders (MBA) is President and acting CEO of the Global Allergy & Airways Patient Platform (GAAPP), representing one billion people living with atopic & airways diseases. With over 25 years in the allergy & asthma industry, she serves on expert panels such as GINA international guidelines, and sits on the We CU board and serves in local ministry. She has authored 100+ peer-reviewed papers and advises AstraZeneca, Chiesi, Eli Lilly, GSK, Novartis, Roche, and Sanofi Regeneron.

Dr Russell is currently a Clinical Reader at Kings College London and a Respiratory Consultant at the Southern Health NHS Foundation Trust. He is the Clinical Director of the West Hampshire Integrated Respiratory Service, looking after COPD and asthma for 2.5 million people. He is the Chair of the British Thoracic Society (BTS) Executive and Council and is active in Asthma+Lung UK. He obtained his PhD at Imperial College and is the founding Editor of the International Journal of COPD.

Prof Bhutani is a Professor of Medicine and the clinical director of the Asthma and COPD clinics at the University of Alberta. Nationally, he is the past Co-chair of the Canadian Thoracic Society (CTS) COPD Clinical Assembly and is a lead author of 2015,17,19 & 23 CTS COPD Pharmacotherapy Guidelines. He was elected to CTS Executive in 2020, was President of CTS from 2023-24 and Co-chair of the Royal College of Physicians & Surgeons Adult Respiratory Examination from 2017-23.

​Ema Paulino completed her pharmaceutical sciences degree at the University of Lisbon. She is a practising pharmacist at her own community pharmacy in Portugal. She is General Manager of Ezfy, a company that engages community pharmacies in the implementation of Patient Support Programmes. She is President of the Portuguese National Association of Pharmacies (ANF).

Prof Han is a Professor of medicine and Chief of the Division of Pulmonary and Critical Care at the University of Michigan Health. She serves on the scientific advisory committees for the COPD Foundation and American Lung Association.